PGS6 COST EFFECTIVENESS OF CONTINUOUS AND ON-DEMAND THERAPY WITH ESOMEPRAZOLE 20MG IN PATIENTS WITH SYMPTOMATIC GASTROESOPHGEAL REFLUX DISEASE (GERD)- THE ONE STUDY
Abstract
Authors
L Edouard D Urbain G Vandenhoven V Duquenne